Comparison of Outcomes Between Multimodal Intraosseous Femoral Injection and Multimodal Intraosseous Tibial Injection, a Randomized Controlled Trial in Simultaneous Bilateral Total Knee Arthroplasty Patients

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In patients with osteoarthritis of the knee whose pain cannot be relieved by conservative treatment, total knee arthroplasty (TKA) is the operation that increases the quality of life for the patient. Pain management after total knee arthroplasty TKA is an important consideration to improve patient outcomes and reduce length of stay. Periarticular injections of the knee are one of the techniques used to reduce pain after surgery. Studies have shown that compared to other methods of pain relief, they are effective and safe. At present, no studies to compare between multimodal intraosseous femoral injection \& multimodal intraosseous tibial injection in Simultaneous Bilateral TKA patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Healthy Volunteers: f
View:

• Patients who will undergo bilateral Total knee Replacement due to osteoarthritis of both knees

• Used of a cemented, PS design TKA surgery.

• Able to give informed consent

Locations
Other Locations
Thailand
Rajavithi hospital
RECRUITING
Phaya Thai
Contact Information
Primary
Thakrit Chompoosang, MD
tk_ortho@hotmail.com
+66846461916
Backup
Tanahem Wijit, MD
troy.erdos@gmail.com
+66956855458
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 20
Treatments
Experimental: Multimodal Intraosseous Femoral Injection
Intraosseous injection of Ketorolac 15mg and Tranexamic acid 500mg in femoral canal
Experimental: Multimodal Intraosseous Tibial Injection
Intraosseous injection of Ketorolac 15mg and Tranexamic acid 500mg in tibial canal
Sponsors
Leads: Department of Medical Services Ministry of Public Health of Thailand

This content was sourced from clinicaltrials.gov